Do you want to read an article? Please log in or register.
New-Onset Nonarteritic Anterior Ischemic Optic Neuropathy and Initiators of Semaglutide in US Veterans With Type 2 Diabetes
Further Publications
COMMENTED
Related content
Retinal Diseases
From Observation to Prediction: Machine Learning Analysis of Progression of Visual loss in Nonarteritic Anterior Ischemic Optic Neuropathy
Am J Ophthalmol
Erekat AN, Williams ZR, Morgenstern R, Szanto D, Wall M, Miller NR, Levin LA, Woods B, Kupersmith MJ, Quark NAION Study Group
doi: 10.1016/j.ajo.2026.02.009
Retinal Diseases
Progression of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) Occurs Early and is Unassociated with Modifiable Risk Factors
Am J Ophthalmol
Williams ZR, Morgenstern R, Erekat AN, Szanto D, Wall M, Miller NR, Levin LA, Woods B, Kupersmith MJ, Quark NAION Study Group
doi: 10.1016/j.ajo.2026.01.012
Retinal Diseases
Rates, Risk Factors, and Progression of Diabetic Retinopathy in Children with Type 1 Diabetes: A 15-Year Retrospective Study from a Regional Center in New Zealand
Pediatr Diabetes
Winter T, Derraik JGB, Jefferies CA, Hofman PL, Shand JAD, Braatvedt GD, Misra SL
doi: 10.1155/2024/5893771
Retinal Diseases
Impact of the era of diabetes onset in a national care system on the prevalence of retinopathy and microalbuminuria in people living with type 1 diabetes 15 years post-diagnosis: A cross-sectional, real-world observational study
Diabetes Obes Metab
Lavens A, De Block C, Oriot P, Philips JC, Vandenbroucke M, Crenier L, Nobels F, Mathieu C, Belgian Group of Experts IQED
doi: 10.1111/dom.70049
COMMENTED
Retinal Diseases
Relationship between free fatty acids and diabetic retinopathy in male patients with type 2 diabetes
★ 2
Recommended and commented by
Prof. emer. Dr Josef Flammer, Faculty Member
Sci Rep
Chen J, Huang Y, Liu C, Chi J, Xu L, Wang Y
doi: 10.1038/s41598-025-07001-w
COMMENTED
Further Publications
Association Between GLP-1 Receptor Agonists and Ischemic Optic Neuropathy: A Meta-analysis
★ 2
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Diabetes Care
Nogueira A, Rassi TNO, Iqbal A, Felix N, Alghaith O, Khan A, Rassi N, Maia M, Moura FA
doi: 10.2337/dc25-1238
COMMENTED
Retinal Diseases
Ocular Outcomes with Tirzepatide Versus Glucagon-like Peptide-1 Receptor Agonists in Type 2 Diabetes
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Ophthalmol Retina
Hong AT, Lin F, Keenan JD, Stewart JM
doi: 10.1016/j.oret.2026.02.002
COMMENTED
Macular DiseasesRetinal Diseases
Potential eye disorders in people with and without Type 2 diabetes mellitus exposed to GLP-1 receptor agonists; an examination of the FAERS (FDA Adverse Event reporting System) database
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Am J Ophthalmol
Murray M, Schifano F, Chiappini S, Corkery JM, Guirguis A
doi: 10.1016/j.ajo.2025.12.015
Retinal Diseases
Effect of a Multifactorial Intervention on Retinopathy in People With Type 2 Diabetes: A Secondary Analysis of the J-DOIT3 Randomized Clinical Trial
JAMA Ophthalmol
Sasako T, Ueki K, Miyoshi K, Miyake K, Aoyama T, Okazaki Y, Ishizuka N, Yamauchi T, Noda M, Kadowaki T, J-DOIT3 Study Group
doi: 10.1001/jamaophthalmol.2025.3819